Collaboration hub For Regulatory Consultancies & CROs

ISO 10993 Support Inside a Wider Regulatory Engagement

Add a bounded biological-evaluation workstream without confusing who owns the client relationship, the wider submission, or the final regulatory decisions.

Discuss a Subcontract or Referral Fit See Example Handoffs
The Practical Problem

Specialist depth may be needed without building permanent capacity.

A consultancy or CRO may own classification, quality, clinical, submission, or programme management while a device-specific ISO 10993 question needs focused attention. The challenge is not simply finding a writer; it is adding biological-evaluation depth without fragmenting the engagement.

MedDev Advisory can take a defined workstream, support a coordinated contributor map, or receive an independent referral. The lead firm's client role and the boundaries of every deliverable remain explicit.

Your firm can retain the wider engagement
The ISO 10993 workstream is bounded in writing
Client visibility and authorship are agreed upfront
Complementary Workstream

Where MedDev Advisory Can Add ISO 10993 Depth

BEP Strategy & Review

Contact classification, endpoint questions, existing-evidence use, gap logic, and a traceable plan for the client file.

BER Drafting & Remediation

Evidence-led report drafting, legacy-file gap assessment, and defined remediation after notified-body or reviewer questions.

Evidence Traceability

Connect device configuration, materials, chemistry, testing, literature, uncertainty, and biological-risk conclusions.

Chemistry-to-TRA Coordination

Structure the evidence handoff while reserving toxicological value selection and acceptability conclusions for appropriately qualified review.

Change & Lifecycle Assessment

Assess whether material, supplier, process, sterilisation, packaging, or use changes alter the biological-evaluation rationale.

Market-Specific Framing

Support biological-evaluation documentation for a stated EU MDR, FDA, or India/CDSCO context without assuming authority outcomes.

Representative Handoffs

How the Work Can Be Divided

These are illustrative operating patterns, not client claims or promises of an identical result.

01

Independent Referral

Your firm identifies a biological-evaluation need outside its chosen scope. MedDev Advisory assesses fit and, if appropriate, contracts directly for that work. Each party remains responsible for its own engagement.

02

Bounded Subcontract

Your firm remains lead. MedDev Advisory drafts or reviews a named BEP, BER, gap analysis, or response workstream against agreed inputs, milestones, review rights, client visibility, and authorship.

03

Coordinated Specialist Map

Your firm, MedDev Advisory, and another qualified contributor own distinct outputs—for example regulatory strategy, biological evaluation, and toxicology—with interfaces and final responsibility documented.

Scope Boundaries

What MedDev Advisory Can—and Cannot—Own

Can provide

  • A defined ISO 10993 documentation deliverable or review workstream
  • Transparent issue logs, assumptions, evidence gaps, and review comments
  • Direct or lead-firm communication according to the written model
  • Independent scientific reasoning within the agreed evidence and qualification boundary

Cannot provide

  • Regulatory clearance, CE marking, notified-body acceptance, or FDA/CDSCO outcomes
  • Laboratory testing or toxicology conclusions outside appropriate qualifications
  • Undisclosed authorship, responsibility, conflicts, or referral incentives
  • Assumption of the manufacturer's or lead firm's legal and regulatory obligations

How a suitable engagement begins

01

Non-Confidential Fit Check

Share the firm type, proposed model, general workstream, timing, and client-visibility preference without device files.

02

Conflict & Boundary Review

Confirm fit, conflicts, independence, authorship, communication path, qualification limits, and whether an NDA is appropriate.

03

Written Scope

Record the contracting party, inputs, deliverables, responsibilities, fees, milestones, review rights, and change process.

04

Controlled Handoff

Deliver the bounded workstream with a traceable issue log, documented review, and explicit final ownership.

Non-Confidential Fit Check

Discuss a Subcontract or Referral Fit

Describe the organisation, proposed relationship, general ISO 10993 workstream, client-visibility preference, and timing. A useful first reply is possible without receiving device files.

Before sending

  • Use non-confidential information only
  • Do not upload client or device files
  • An NDA or written boundary can follow after fit and conflict review
No device files or confidential client information at this stage.0 / 1400

Initial enquiry only. Do not include client names unless authorised, patient information, unpublished technical files, passwords, access links, or confidential device data.

Submission is delivered to MedDev Advisory by FormSubmit and used to assess and respond to this collaboration enquiry, as described in the Privacy Policy.

Trust & Confidentiality